No Picture
Boston Cambridge Biotech Trending News

Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S.

BEIJING, SHANGHAI and BOSTON, March 1, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced it received IND (Investigational New Drug) approval of its self-developed drug JAB-30300 (P53 […]

No Picture
DC Maryland Virginia Biotech Trending News

Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia

ROCKVILLE, Md. and SUZHOU, China, Feb. 29, 2024 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune,… Click […]

Boston Cambridge Biotech Trending News

With $39M in seed funding, Worcester startup aims to develop ALS, schizophrenia treatments

Leal Therapeutics, a startup headquartered in Worcester, has emerged from operating in stealth mode for the past two years with an ambitious goal: developing breakthroughs to lead to effective treatments for diseases impacting the central […]

No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report fourth quarter and full […]

News

PHYSICIANS AND ADVANCED PRACTICE PROVIDERS AT BICYCLE HEALTH, A NATIONAL TELEHEALTH TREATMENT PROGRAM FOR OPIOID USE DISORDER, FILE TO UNIONIZE

SAN JOSE, Calif., Feb. 29, 2024 /PRNewswire/ — In a historic move for the healthcare and technology sectors, physicians, physician assistants, and nurse practitioners at Bicycle Health have filed with the National Labor Relations Board […]